Lysle Kevin Lewis

Title: Lysle Kevin Lewis: Innovator in In Vivo Site-Directed Mutagenesis

Introduction

Lysle Kevin Lewis is a notable inventor based in San Marcos, TX (US). He has made significant contributions to the field of genetic engineering, particularly in the area of in vivo site-directed mutagenesis. His innovative approaches have the potential to advance research in various biological systems.

Latest Patents

Lysle Kevin Lewis holds a patent for "Systems for in vivo site-directed mutagenesis using oligonucleotides." This patent outlines several methods to generate nucleic acid mutations in vivo, ensuring that no heterologous sequence is retained after the mutagenesis is complete. The methods utilize integrative recombinant oligonucleotides (IROs) and enable site-specific point mutations, deletions, and insertions. Additionally, the patent describes methods that facilitate multiple rounds of mutation and random mutagenesis in localized regions, applicable to any organism with a homologous recombination system.

Career Highlights

Lysle Kevin Lewis is associated with the United States of America, as represented by the Secretary, Department of Health and Human Services. His work has contributed to advancements in genetic research and therapeutic applications.

Collaborations

Lysle has collaborated with notable colleagues, including Francesca Storici and Michael A Resnick. Their combined expertise has furthered the development of innovative methodologies in genetic engineering.

Conclusion

Lysle Kevin Lewis is a prominent figure in the field of genetic engineering, with a focus on in vivo site-directed mutagenesis. His contributions through patents and collaborations continue to influence research and applications in biotechnology.